62.09 +0.77 (1.26%)
Pre-Market: 6:00AM EST
|Bid||61.87 x 800|
|Ask||61.92 x 800|
|Day's Range||60.87 - 61.58|
|52 Week Range||53.78 - 63.73|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||64.80|
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]
We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 52% and 49% respectively. Hedge funds' top 3 stock picks returned 39.1% this year and beat the S&P […]
In a Q&A with Barron’s, the longtime credit investor discusses where to find value in an increasingly expensive market, his firm’s bet on Puerto Rico’s distressed debt, and why he like’s some Argentine debt.
GENEVA-- -- Third quarter sales of $1.8 billion, an increase of 4%, or 6% constant currency Expands new product pipeline with the successful launch of PanOptix and PRECISION1 in the US Announces a transformation program that reinvests savings into strategic growth initiatives supporting its long-term financial goals Alcon , the global leader in eye care, reported its financial results for the third ...
Alcon (ALC.SW) (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today that it will report third quarter 2019 results and host a conference call on Wednesday, November 20, at 2:00 p.m. Central European Time / 8:00 a.m. Eastern Time for the quarter ended September 30, 2019. A news release including financial results will be issued on Tuesday, November 19, at 10:30 p.m. Central European Time / 4:30 p.m. Eastern time and will be available at http://www.investor.alcon.com. This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Alcon.
ORLANDO, Fla.-- -- Head-to-head data presentations will show PRECISION1 superior over competitive lenses on critical success factors for new contact lens wearers Clinical findings on AcrySof IQ PanOptix trifocal intraocular lens for the treatment of cataracts to be presented for the first-time ever at a major optometry meeting Robust onsite program will give meeting goers hands-on experiences with ...
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American Academy of Ophthalmology (AAO) Annual Meeting on October 12-15 in San Francisco, CA. The newly launched AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), along with findings from the AAO IRIS® (Intelligent Research in Sight) Registry, will be part of the scientific program.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 16) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alder ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) DURECT Corporation (NASDAQ: DRRX ) Stoke Therapeutics ...